Spectral Medical Announces U.S. FDA Approval of Tigris Trial Protocol Amendment to Expand Inclusion Criteria

Stock Information for Spectral Medical Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Spectral Medical Inc.

Spectral Medical Provides Tigris Trial Update
Spectral Medical Chair to Retire From the Board of Directors
Spectral Medical Announces Fourth Quarter and Fiscal 2023 Results and Provides Corporate Update
Spectral Medical Provides February Tigris Trial Update
Spectral Medical Announces Amendment and Extension of Exclusive Supply and Distribution Agreement With Baxter Healthcare Corporation
Spectral Medical Announces Major Milestone by Reaching Its Interim Enrollment Target of 90 Patients
Spectral Medical Provides Early February Tigris Trial Update
Spectral Medical Provides January Tigris Trial Update

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.